You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PTLD

Showing 1 - 25 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Post-transplant Lymphoproliferative Disorder Trial in Saint Louis (Polatuzumab vedotin, Rituximab, CHP)

Not yet recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Polatuzumab vedotin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 9, 2023

Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 16, 2023

PTLD, CAEBV, HLH Trial in Beijing (low-dose CD20 mAb injection)

Enrolling by invitation
  • PTLD
  • +2 more
  • low-dose CD20 monoclonal antibody injection
  • Beijing, Beijing, China
    Beijing Friendship Hospital
Feb 24, 2022

Post-Lyme Disease Syndrome Trial (Tetracycline 500 Mg, Placebo)

Enrolling by invitation
  • Post-Treatment Lyme Disease
  • Tetracycline 500 Mg
  • Placebo
  • Lutherville, Maryland
    Johns Hopkins Lyme Disease Research Center
Nov 4, 2022

Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

Completed
  • Posttransplant Lymphoproliferative Disorder
  • Rituximab sc
  • +3 more
  • Aachen, Germany
  • +17 more
Aug 22, 2022

EBV Emia and EBV Positive PTLD After Allogenic HSCT Trial in Sanhe (EBV-TCR-T cells)

Completed
  • EBV Emia and EBV Positive PTLD After Allogenic HSCT
  • EBV-TCR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Mar 6, 2022

EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

Not yet recruiting
  • EBV Lymphoma
  • Post-transplant Lymphoproliferative Disease (PTLD)
  • Donor-derived ex-vivo expanded EBV Tscm CTL
  • Basel, Switzerland
  • +7 more
Jan 25, 2023

Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

Available
  • Epstein-Barr Virus (EBV) Infections
  • +11 more
  • tabelecleucel
  • (no location specified)
Feb 15, 2022

NonHodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Lymphoma Trial in Houston (EBVST Cells, Nivolumab)

Completed
  • NonHodgkin Lymphoma
  • +6 more
  • EBVST Cells
  • Nivolumab
  • Houston, Texas
  • +1 more
Jul 19, 2021

Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+

Recruiting
  • Epstein-Barr Virus (EBV)-Associated Diseases
  • +13 more
  • Tabelecleucel
  • Los Angeles, California
  • +39 more
Nov 9, 2022

Epstein-Barr Virus Infection moniToring in renAl Transplant

Recruiting
  • EBV Infection
  • +3 more
  • EBV DNA in whole blood and plasma
  • Aarhus, Central Region Denmark, Denmark
  • +2 more
Dec 12, 2022

Early Detection of Epstein-Barr Virus Related Disease.

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • +8 more
    • Aarhus, Central Region Of Denmark, Denmark
      Aarhus University Hospital
    Dec 12, 2022

    Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

    Recruiting
    • Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
    • +4 more
    • tabelecleucel
    • Duarte, California
    • +70 more
    Jun 23, 2022

    Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications,

    Completed
    • Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
    • +2 more
    • tabelecleucel
    • La Jolla, California
    • +26 more
    Mar 24, 2021

    Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder Trial

    Not yet recruiting
    • Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
    • Polymorphic Post-Transplant Lymphoproliferative Disorder
    • Biopsy
    • +5 more
    • New Brunswick, New Jersey
    • +2 more
    Mar 23, 2023

    Risk Factors and Biomarkers for Post-tuberculosis Lung Damage

    Recruiting
    • Pulmonary TB
    • no intervention
    • Beijing, China
    • +1 more
    Jun 16, 2022

    Post-Treatment Lyme Disease, Chronic Lyme Disease, Lyme Disease, Chronic Trial in Baltimore (Psilocybin)

    Enrolling by invitation
    • Post-Treatment Lyme Disease
    • +2 more
    • Baltimore, Maryland
      Behavioral Pharmacology Research Unit
    Aug 2, 2022

    Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy Trial in London (Autologous EBV-CTL

    Active, not recruiting
    • Post-transplant Lymphoproliferative Disease
    • Transplant-Related Hematologic Malignancy
    • Autologous EBV-CTL transduced with vector SFG-CNA12
    • +2 more
    • London, United Kingdom
    • +1 more
    Jan 19, 2022

    Epstein-Barr Virus Associated Lymphoproliferative Disorder, EBV-Related PTLD, EBV Related Non-Hodgkin's Lymphoma Trial in

    Recruiting
    • Epstein-Barr Virus Associated Lymphoproliferative Disorder
    • +7 more
    • Nanatinostat in combination with valganciclovir
    • Birmingham, Alabama
    • +57 more
    Aug 10, 2022

    Epstein-Barr Viraemia, Hematologic Diseases, Allogeneic Disease Trial in Paris (biological collection)

    Completed
    • Epstein-Barr Viraemia
    • +2 more
    • biological collection
    • Paris, France
      Service d'hématologie Clinique
    Oct 22, 2021

    Post-Treatment Lyme Disease Trial in New York (taVNS)

    Not yet recruiting
    • Post-Treatment Lyme Disease
    • taVNS
    • New York, New York
      Lyme and Tick-Borne Diseases Research Center
    Mar 8, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    Pediatric Heart Transplantation, Immunosuppression, Chronic Kidney Diseases Trial in United States (Everolimus, Tacrolimus,

    Active, not recruiting
    • Pediatric Heart Transplantation
    • +6 more
    • Birmingham, Alabama
    • +24 more
    Sep 2, 2021

    EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

    Recruiting
    • EBV Infection After Allogenic HSCT
    • EBV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 3, 2023

    Advanced Solid Tumor and Lymphoma Malignancies Trial in Worldwide (TAK-659)

    Completed
    • Advanced Solid Tumor and Lymphoma Malignancies
    • Sarasota, Florida
    • +14 more
    Jul 15, 2021